Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Radiation Oncology
•
Genitourinary Cancers
Do you recommend ADT for a high risk prostate cancer patient who had SBRT?
If so, how long?
Answer from: Radiation Oncologist at Community Practice
SBRT doesn’t mitigate benefit of ADT and the type and duration have to be the same as with EBRT or EBRT plus brachytherapy.
Comments
Radiation Oncologist at Genesis Healthcare Partners- San Diego
Since ADT has no benefit in high risk prostate ca ...
Radiation Oncologist at Varian Medical Systems/Allegheny health network
Ma et al., PMID 35934601 This article highlight...
6993
6998
Sign in or Register to read more
Answer from: Radiation Oncologist at Academic Institution
I would not treat a high risk patient with SBRT.
Sign in or Register to read more
14207
14233
Related Questions
Do you recommend radiation in a patient with BAP1Tumor Predisposition Syndrome with prior RCC with recurrent brain met after previous resection?
How does a negative PSMA PET change your management when completing salvage radiation for prostate cancer?
How do you dose or sequence therapy to overcome radioresistance from oligometastatic disease from RCC?
What constraints do you use for SBRT near the renal vessels?
Is it safe to administer Lu 177 therapies in patients with epidural disease in the spinal canal?
Would you include the entire bladder in the treatment field of a patient with a history of T1 bladder cancer s/p intravesical therapy who is now being planned for chemoradiation for a T3N1 rectal cancer?
Would you offer prostate SBRT to a patient who cannot have an MRI?
Is there a benefit in proactively referring patients treated with pelvic radiation to see pelvic rehabilitation in the absence of any symptoms?
Would you consider pelvic radiation in a patient with prostate cancer and myelofibrosis with mild cytopenias?
How would you approach a patient with prostate cancer with PSMA+ non-regional lymph nodes?
Since ADT has no benefit in high risk prostate ca ...
Ma et al., PMID 35934601 This article highlight...